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eAppendix. Supplementary Methods 
Spline knots and locations. 
Each spline model was constructed using 5 knots with the following locations: 
 












Testing proportional hazards assumption for time variables. 
ZPH tests for delay variable (>12 weeks) and spline terms in both cox proportional hazards 
model and recurrence competing risk model. (Note: a p-value of less than 0.05 indicates a 
violation of the PH assumption.) 
 
ZPH Test for Nonproportional Hazards 
(Overall Survival) 
Time variable P-value 
Delayed surgery (>12 weeks) 0.2639 
Spline term (#1) 0.3559 
Spline term (#2) 0.3981 
Spline term (#3) 0.4703 
Spline term (#4) 0.6400 
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ZPH Test for Nonproportional Hazards 
(Recurrence) 
Time variable P-value 
Delayed surgery (>12 weeks) 0.4551 
Spline term (#1) 0.1345 
Spline term (#2) 0.2480 
Spline term (#3) 0.2514 
Spline term (#4) 0.2482 
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eFigure1. Cumulative Incidence Function for Recurrence. 
Cumulative incidence function for recurrence using multivariable competing risk model based on 
several rTTS cutoffs (4-, 8-, 12-, 16-weeks). 
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eFigure2. Direct Adjusted Survival Curve Following Delayed Surgical Treatment 
Multivariable direct adjusted overall survival curve for clinical stage I NSCLC patients with 
delayed (>12 weeks) versus non-delayed (<12 weeks) surgery. 
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eFigure3. Association between Clinical Time to Surgical Treatment and Probability of 
Recurrence 
Restricted cubic spline model for relationship between cTTS and recurrence. 
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eTable 1. Multivariable Analysis of Factors Associated With Upstaging 
Variable Odds Ratio 95% Wald 
Confidence Limits 
P-value 
Age, y 0.985 0.975 0.996 0.0061 
Female vs male, sex 1.022 0.715 1.461 0.9062 
Race (reference = white)     
  Black 1.069 0.886 1.289 0.1739 
  Other 0.678 0.347 1.323 0.2178 
BMI 1.022 1.009 1.035 0.0011 
Smoking status (reference = current)     
  Former 1.028 0.889 1.188 0.8602 
  Never 0.980 0.436 2.203 0.9342 
CCI 1.003 0.968 1.039 0.8876 
ADI 1.006 1.001 1.011 0.0161 
Surgical year, y 1.040 1.014 1.067 0.0027 
Yearly hospital caseload, y 1.001 1.000 1.002 0.1459 
EBUS or mediastinoscopy vs none 1.148 0.971 1.357 0.1066 
Type of operation (reference = lobectomy)     
  Pneumonectomy 3.528 2.415 5.153 <.0001 
  Segmentectomy 0.620 0.431 0.892 <.0001 
  Wedge 0.826 0.678 1.007 0.0004 
Incision type (reference = thoracotomy)     
  VATS 0.878 0.754 1.022 0.0010 
  Unknown 1.318 1.045 1.663 0.0024 
Histology (reference = adenocarcinoma)     
  Squamous cell carcinoma 0.721 0.618 0.841 0.0073 
  Other 0.816 0.652 1.021 0.7168 
Grade (reference = I)     
  II 2.447 1.859 3.302 0.0907 
  III 3.145 2.341 4.224 <.0001 
  IV 2.638 1.405 4.954 0.3304 
Tumor size (reference = 0-10mm)     
  11-20mm 1.076 0.791 1.464 <.0001 
  21-30mm 1.645 1.206 2.242 0.0689 
  31-40mm 1.734 1.250 2.407 0.0273 
  40+ mm 2.545 1.789 3.619 <.0001 
  Unknown 1.138 0.662 1.957 0.2395 
Lymph node collection (reference <10)     
  ≥10 1.476 1.275 1.709 0.0091 
  Unknown 1.352 1.017 1.797 0.4481 
ADI, area deprivation index; CCI, Charlson comorbidity index; EBUS, endobronchial ultrasound; 
VATS, video-assisted thoracoscopic surgery 
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eTable 2. Multivariable Analysis of Factors Associated With Positive Surgical Margin 
Variable Odds Ratio 95% Wald 
Confidence Limits 
P-value 
Age, y 0.983 0.965 1.002 0.0763 
Female vs male, sex 1.410 0.767 2.592 0.2691 
Race (reference = white)     
  Black 1.057 0.752 1.487 0.7974 
  Other 0.940 0.293 3.010 0.8802 
BMI 0.993 0.970 1.017 0.5675 
Smoking status (reference = current)     
  Former 1.166 0.892 1.524 0.9653 
  Never <0.001 <0.001 >999.999 0.9660 
CCI 1.053 0.990 1.120 0.1015 
ADI 1.003 0.995 1.010 0.5055 
Surgical year, y 0.994 0.948 1.042 0.7988 
EBUS or mediastinoscopy vs none 0.920 0.655 1.292 0.6300 
Type of operation (reference = lobectomy)     
  Pneumonectomy 0.864 0.310 2.409 0.3355 
  Segmentectomy 1.197 0.668 2.144 0.8173 
  Wedge 2.501 1.866 3.352 0.0001 
Incision type (reference = thoracotomy)     
  VATS 0.915 0.690 1.212 0.3935 
  Unknown 1.081 0.696 1.679 0.5643 
Histology (reference = adenocarcinoma)     
  Squamous cell carcinoma 1.096 0.830 1.447 0.3712 
  Other 0.915 0.594 1.408 0.5219 
Grade (reference = I)     
  II 1.217 0.771 1.922 0.2830 
  III 1.883 1.183 2.996 0.0712 
  IV 1.852 0.656 5.233 0.4877 
Tumor size (reference = 0-10mm)     
  11-20mm 1.259 0.740 2.144 0.9607 
  21-30mm 1.703 0.988 2.935 0.1513 
  31-40mm 1.848 1.026 3.329 0.0915 
  40+ mm 3.087 1.651 5.771 0.0002 
  Unknown 0.346 0.045 2.647 0.1222 
Lymph node collection (reference <10)     
  ≥10 0.822 0.612 1.104 0.9365 
  Unknown 0.698 0.373 1.305 0.4097 
ADI, area deprivation index; CCI, Charlson comorbidity index; EBUS, endobronchial ultrasound; 
VATS, video-assisted thoracoscopic surgery  
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eTable 3. Multivariable Analysis of Factors Associated With Cancer Recurrence 
Variable Hazard Ratio 95% Wald 
Confidence Limits 
P-value 
Age, y 0.992 0.987 0.997 0.0025 
Female vs male, sex 0.844 0.703 1.013 0.0687 
Race (reference = white)     
  Black 0.985 0.900 1.078 0.7451 
  Other 1.193 0.910 1.563 0.2006 
BMI 0.994 0.988 1.001 0.0925 
Smoking status (reference = current)     
  Former 0.968 0.902 1.038 0.3582 
  Never 0.977 0.662 1.443 0.9087 
CCI 1.055 1.037 1.073 <.0001 
ADI 0.999 0.997 1.001 0.2680 
Surgical year, y 0.986 0.974 0.999 0.0291 
Yearly hospital caseload, y 1.000 1.000 1.001 0.3970 
EBUS or mediastinoscopy vs none 1.063 0.976 1.158 0.1614 
Type of operation (reference = lobectomy)     
  Pneumonectomy 0.832 0.620 1.117 0.2210 
  Segmentectomy 1.352 1.179 1.551 <.0001 
  Wedge 1.282 1.179 1.394 <.0001 
Incision type (reference = thoracotomy)     
  VATS 0.943 0.876 1.014 0.1126 
  Unknown 0.860 0.755 0.981 0.0243 
Histology (reference = adenocarcinoma)     
  Squamous cell carcinoma 0.957 0.887 1.031 0.2477 
  Other 1.143 1.029 1.270 0.0131 
Grade (reference = I)     
  II 1.210 1.085 1.349 0.0006 
  III 1.348 1.201 1.513 <.0001 
  IV 1.438 1.089 1.899 0.0105 
Tumor size (reference = 0-10mm)     
  11-20mm 0.911 0.806 1.029 0.1326 
  21-30mm 1.001 0.881 1.137 0.9922 
  31-40mm 1.209 1.051 1.390 0.0079 
  40+ mm 1.379 1.169 1.627 0.0001 
  Unknown 1.249 0.980 1.592 0.0722 
Lymph node collection (reference <10)     
  ≥10 0.866 0.803 0.933 0.0002 
  Unknown 0.958 0.832 1.103 0.5519 
30-day readmission vs none 1.125 0.996 1.270 0.0576 
Pathologic stage (reference = I)     
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  II 1.121 0.992 1.266 0.0675 
  III 1.575 1.351 1.837 <.0001 
ADI, area deprivation index; CCI, Charlson comorbidity index; EBUS, endobronchial ultrasound; 
VATS, video-assisted thoracoscopic surgery 
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eTable4. Multivariable Analysis of Factors Associated With Overall Survival 
Variable Hazard Ratio 95% Wald 
Confidence Limits 
P-value 
rTTS (reference <12 weeks) 1.132 1.064 1.204 <.0001 
Age, y 1.022 1.017 1.026 <.0001 
Female vs male, sex 0.721 0.599 0.868 0.0005 
Race (reference = white)     
  Black 0.816 0.750 0.887 <.0001 
  Other 0.821 0.629 1.073 0.1487 
BMI 0.976 0.970 0.981 <.0001 
Smoking status (reference = current)     
  Former 0.821 0.772 0.873 <.0001 
  Never 0.554 0.373 0.823 0.0034 
CCI 1.112 1.096 1.128 <.0001 
ADI 1.001 0.999 1.002 0.6034 
Surgical year, y 0.972 0.961 0.983 <.0001 
Yearly hospital caseload, y 0.999 0.999 1.000 0.0142 
EBUS or mediastinoscopy vs none 1.068 0.990 1.151 0.0874 
Type of operation (reference = lobectomy)     
  Pneumonectomy 1.244 1.009 1.534 0.0408 
  Segmentectomy 1.073 0.942 1.222 0.2879 
  Wedge 1.289 1.198 1.386 <.0001 
Incision type (reference = thoracotomy)     
  VATS 1.024 0.961 1.091 0.4691 
  Unknown 0.992 0.889 1.108 0.8914 
Histology (reference = adenocarcinoma)     
  Squamous cell carcinoma 1.143 1.072 1.219 <.0001 
  Other 1.147 1.045 1.260 0.0039 
Grade (reference = I)     
  II 1.196 1.083 1.322 0.0004 
  III 1.355 1.220 1.504 <.0001 
  IV 1.368 1.066 1.756 0.0138 
Tumor size (reference = 0-10mm)     
  11-20mm 1.020 0.913 1.139 0.7289 
  21-30mm 1.073 0.957 1.203 0.2292 
  31-40mm 1.254 1.107 1.421 0.0004 
  40+ mm 1.256 1.087 1.452 0.0020 
  Unknown 0.569 0.418 0.774 0.0003 
Lymph node collection (reference <10)     
  ≥10 0.924 0.865 0.987 0.0182 
  Unknown 0.999 0.884 1.128 0.9855 
30-day readmission vs none 1.153 1.040 1.277 0.0066 
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Pathologic stage (reference = I)     
  II 1.389 1.252 1.541 <.0001 
  III 1.968 1.728 2.241 <.0001 
Recurrence (reference = none) 1.391 1.313 1.474 <.0001 
ADI, area deprivation index; CCI, Charlson comorbidity index; EBUS, endobronchial ultrasound; 
VATS, video-assisted thoracoscopic surgery 
 
